compare tirzepatide vs semaglutide for weight loss Tirzepatide: Key Differences Tirzepatide vs. Semaglutide: Which is

Franzese, A., Iannilli, A., Mozzillo, E., Mastrandrea, V., & Bonora, E

The Wegovy pill was approved by the UK's MHRA based primarily on robust data from a large Phase 3 study called OASIS 4 , which demonstrated: Average weight loss of around 14% in the main analysis Up to 16-17% weight loss in people who stayed on their treatment plan as directed Weight loss on a completely similar scale to injectable Wegovy 2.4 mg in comparable clinical programmes Oral semaglutide is now fully approved, licensed, and available to be prescribed privately in the UK

The practical travel implications For most travelers, this table is the most useful thing in this guide

N Engl J Med 375 , 18341844 (2016)